1 / 38

Chronic Heart Failure GP Clinical update 11/11/09

Chronic Heart Failure GP Clinical update 11/11/09. Dr Paul Armitage GP Heart Failure Specialist, Dorset PCT Tracey Dare Heart Failure Nurse Specialist, DCH. Chronic Heart Failure.

zanna
Download Presentation

Chronic Heart Failure GP Clinical update 11/11/09

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chronic Heart FailureGP Clinical update 11/11/09 Dr Paul Armitage GP Heart Failure Specialist, Dorset PCT Tracey Dare Heart Failure Nurse Specialist, DCH

  2. Chronic Heart Failure “There is no disease that you either have or don’t have – except perhaps Sudden Death or Rabies. All other diseases you either have a little or a lot of” Geoffrey Rose

  3. Chronic Heart Failure- setting the scene • Common 1-2%of the population • Costly 1-2% of NHS budget • Disabling symptoms have large impact on quality of life • Deadly mortality 30% at 12 months but improving steadily • Increasing ageing population/more effective treatment for CHD

  4. What is Heart Failure – key facts • Heart Pump Inefficiency – either primarily a disorder of filling or of emptying (Tinsley R Harrison, 1950) • Most common cause is LV muscle damage • Various conditions may predispose to, or cause, such muscle damage

  5. Guess who?

  6. Causes of Chronic HF (UK only – Fox et al, European Heart Journal 2001) • Coronary Heart Disease 52% • Chronic hypertension 4% • Idiopathic 13% • Valvular dysfunction 10% • Cardiac arrhythmias 3% • Alcohol 4% • Other 4% • Undetermined 10%

  7. Prevalence • CHD increasing • Ageing population • Better CHD acute phase care • Better CHF management • West Dorset Population - prevalence estimate 4,500 (sex & age specific calculations, 2002)

  8. Incidence • 1- 4 new cases per 1000 population each year • Incident rate rises to more than 10 cases per 1000 in those aged 85 years and over • Male:female = 2:1 • West Dorset population - incidence estimate 330 new cases per year (sex & age specific calculations, 2002)

  9. Guess who ?

  10. Mortality • Mild – moderate CHF – 20% at 1 year • Severe - >50% at 1 year • Survival all classes – 30% at 8 years • 80% mortality in men within 6 years of diagnosis • Class II – sudden death risk

  11. Health Service Use • HF accounts for 5% of all hospital admissions • Patients frequently admitted • Bed occupancy average 20 days each admission • £360 million (hospitalisations = 59.5%)

  12. Guess who?

  13. Why so difficult? • Symptoms non-specific • Clinical signs insensitive • Definition of heart failure disputed • Poor primary care access to cardiac investigations eg BNPs and echocardiography

  14. Conditions presenting with similar symptoms • Obesity • Chest disease • Venous insufficiency in lower limbs • Drug induced ankle swelling (calcium channel blockers) • Drug induced fluid retention (NSAIDs) • Hypoalbuminaemia • Intrinsic renal or hepatic disease • Pulmonary embolic disease • Severe anaemia or thyroid disease • Bilateral renal artery stenosis

  15. Symptoms – may not be terribly helpful! • Shortness of breath on exertion • Decreased exercise tolerance • PND • Orthopnoea • Ankle swelling

  16. Guess who?

  17. Clinical signs • The most specific signs are: • Laterally displaced apex beat • Elevated JVP • 3rd heart sound • Less specific signs: • Tachycardia • Lung crepitations • Hepatic engorgement • Peripheral oedema

  18. Investigations • 12 lead ECG • Chest X-ray • FBC, U&E, TFT, LFT, glucose, lipids, urinalysis, peak flow • BNP where available • Echocardiography (open access available locally) • NB: If ECG is normal - it is very unlikely that the diagnosis is heart failure. Same for BNP

  19. Guess who?

  20. How useful is BNP? • 96% as useful as a panel of cardiologists • NB CTR on CXR is only 79% as useful as a panel of cardiologists • (the gold standard was an expert panel diagnosis blinded to BNP results) • Lancet 1997; 350:1349-53

  21. To diagnose Heart Failure 3 things are essential: • 1. Patient • 2. BNP • 3. ECHO Awaiting new NICE guidelines (PCTs beware!)

  22. Guess who?

  23. CHF management • Establish cause (angiography, CDM screen) and treat appropriately • Evidence based pharmacological treatments (ACEi, Beta blockers, aldosterone antagonists) • Device therapy (CRT-P, CRT-D) • Self management/ lifestyle advice • Heart Failure Services • Liaison/ onward referrals (CKD team, PPM techs, arrhythmia nurse, Smoke Stop, Dieticians, Cardiac Rehab, pharmacists, Community Matrons, PC Team)

  24. ACE inhibitors • HOPE = Heart Outcomes Prevention Evaluation Study • CONSENSUS = Co-operative North Scandinavian Enalapril Survival Study • SOLVD = Studies of Left Ventricular Dysfunction • All grades of CHF unless specific contraindications • Cautions • Significant renal dysfunction, bilateral renal artery stenosis, symptomatic/ severe asymptomatic hypotension, K+ supplements/ K+ sparing diuretics

  25. ACE inhibitors

  26. Cardio-selective Beta blockers • Undisputed evidence. Recommended in NICE guidelines • Reduction in HF exacerbations • Reduction in hospitalizations and bed days • Improved symptoms/ NYHA class/ QOL • Reduces mortality

  27. Beta blocker Trials • CIBIS (1994) and CIBIS II (1999) (The Cardiac Insufficiency Bisoprolol Study) • COPERNICUS (CarvedilOl ProspEctive RaNdomIzed Cumulative Survival) 2001 • CAPRICORN (Effect of Carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction) 2001 • SENIORS (Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with heart failure) • Undisputed evidence from various studies

  28. Beta blockers • Beta-blocker titration • Bisoprolol 1.25mg, 2.5mg, 3.75mg, 5mg, 7.5mg, 10mg • Carvedilol 3.125mg BD, 6.25mg BD, 12.5mg BD, 25mg BD • Nebivolol 1.25mg, 3.5mg, 5mg, 7.5mg, 10mg

  29. Aldosterone antagonists • Consider for moderate to severe HF already on ACEi and loop diuretic • Spironolactone 25mg (increase to 50mg if necessary) • Epleronone 25mg (increase as above) NB licensed for post MI only but consider for all patients if Spironolactone causes hormonal side effects • NB Renal function monitoring

  30. Other pharmacological considerations • Co-morbidities/ polypharmacy • Compliance and understanding • Blister packs • Timely interface communication of drug dose changes

  31. Heart Failure Service Dorset County Hospital • Set up in response to NSF 2001 • Aim to optimise pharmacological therapy through series of out patient visits • Patient education (BHF Heart Failure Plan). Medication concordance and treatment compliance. • Monitoring • Support & point of contact • Interface link. Onward referrals

  32. Heart Failure Service Dorset County Hospital • Clinic based intervention only • x1 Full time HF Nurse Specialist • GP Heart Failure Specialist x2 sessions per week • Service provision includes:- • Dorset County Hospital (x2 per week, plus some in-patient cover dependant on availability) • Weymouth (x2.5 per week) • Bridport Community Clinic (x1 per week)

  33. Heart Failure Service Dorset County Hospital • Service population 229,836 • Estimate 4,500 prevalence and 330 new patients per year • Total referrals up to end of year 8 = 1489 (187 per year) • 301 patients on present active caseload (as of 3/11/09)

  34. Heart Failure Service Dorset County Hospital

  35. Heart Failure Management • Complex condition to manage • Timely recognition/ diagnosis/ treatment of underlying causes results in best outcomes and more cost effective in the long run • Open access echo service – direct route of referral to the HF service • Pharmacological therapy is only part of the management but a big part of the heart failure service work

  36. Heart Failure Service • Referrals from GPs can be accepted if the patient already has a confirmed diagnosis and previously known to Cardiology Consultants • Open access ECHOs – if heart failure confirmed this will result in direct referral to the service for assessment/ further investigations and formulation of management plan • Limited service provision (no domiciliary service) but willing and happy to help where we can. To discuss any patient on an individual basis – please contact us via Dorset County Hospital 01305 255610 (24 hour voicemail) Tracey.Dare@dchft.nhs.uk

  37. Q. Why are they no longer with us?

  38. Answers: • 1. Late diagnosis • 2. GP didn’t have access to BNP or Heart Failure Services • 3. Beta blockers not available in Chechnia • 4. Too much cocaine/ alcohol

More Related